89 related articles for article (PubMed ID: 211963)
1. [Activity of the alternative complement pathway by various axenic strains of Entamoeba histolytica].
Capin NR; Capin R; Zamacona G; Ortiz-Ortiz L
Arch Invest Med (Mex); 1978; 9 Suppl 1():291-6. PubMed ID: 211963
[TBL] [Abstract][Full Text] [Related]
2. Activation of the alternative pathway of complement by Entamoeba histolytica.
Ortiz-Ortiz L; Capin R; Capin NR; Sepúlveda B; Zamacona G
Clin Exp Immunol; 1978 Oct; 34(1):10-8. PubMed ID: 219975
[TBL] [Abstract][Full Text] [Related]
3. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica.
Reed SL; Curd JG; Gigli I; Gillin FD; Braude AI
J Immunol; 1986 Mar; 136(6):2265-70. PubMed ID: 2869084
[TBL] [Abstract][Full Text] [Related]
4. Entamoeba histolytica: surface proteolytic activity and its relationship with in vitro virulence.
Araiza-Orozco LM; Avila EE; Muñoz ML; Arias-Negrete S
Folia Parasitol (Praha); 1999; 46(3):161-7. PubMed ID: 10553649
[TBL] [Abstract][Full Text] [Related]
5. [An in vitro model for the quantitative study of E. histolytica virulence].
Orozco E; Martínez-Palomo A; Lopez-Revilla R
Arch Invest Med (Mex); 1978; 9 Suppl 1():257-60. PubMed ID: 211959
[TBL] [Abstract][Full Text] [Related]
6. Virulence of Entamoeba histolytica correlates with the capacity to develop complement resistance.
Mogyoros M; Calef E; Gitler C
Isr J Med Sci; 1986 Dec; 22(12):915-7. PubMed ID: 2883155
[No Abstract] [Full Text] [Related]
7. [Axenic cultures of Mexican strains of E. histolytica HM2: IMSS and HM3: IMSS].
de la Torre M; de la Hoz R; Filloy L
Arch Invest Med (Mex); 1974; 5 SUPPL 2():279-82. PubMed ID: 4376910
[No Abstract] [Full Text] [Related]
8. Activation of the alternative and classical complement pathways by Entamoeba histolytica.
Calderon J; Schreiber RD
Infect Immun; 1985 Nov; 50(2):560-5. PubMed ID: 2865212
[TBL] [Abstract][Full Text] [Related]
9. Interaction of pathogenic and nonpathogenic Entamoeba histolytica with human complement.
Reed SL; Gault M; Gillin FD; Gigli I; Braude AI; Curd JG; Sargeaunt PG
Arch Invest Med (Mex); 1987; 18(2):141-9. PubMed ID: 2889433
[No Abstract] [Full Text] [Related]
10. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
Schenkein HA; Ruddy S
J Immunol; 1981 Jan; 126(1):7-10. PubMed ID: 6778918
[TBL] [Abstract][Full Text] [Related]
11. Entamoeba histolytica inhibits the respiratory burst of polymorphonuclear leukocytes.
Arbo A; Hoefsloot M; Ramírez A; Ignacio Santos J
Arch Invest Med (Mex); 1990; 21 Suppl 1():57-61. PubMed ID: 2136504
[TBL] [Abstract][Full Text] [Related]
12. Lysozyme and complement-dependent lysis of Entamoeba histolytica. Inhibition by leupeptin.
Mogyoros M; Fishelson Z; Gitler C
Isr J Med Sci; 1986 Dec; 22(12):918-20. PubMed ID: 2883156
[No Abstract] [Full Text] [Related]
13. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen.
Liang-Takasaki CJ; Grossman N; Leive L
J Immunol; 1983 Apr; 130(4):1867-70. PubMed ID: 6187823
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica.
Reed SL; Keene WE; McKerrow JH; Gigli I
J Immunol; 1989 Jul; 143(1):189-95. PubMed ID: 2543700
[TBL] [Abstract][Full Text] [Related]
15. Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinase.
Reed SL; Gigli I
J Clin Invest; 1990 Dec; 86(6):1815-22. PubMed ID: 2254446
[TBL] [Abstract][Full Text] [Related]
16. Effect of bacterial association on virulence of Entamoeba histolytica to baby hamster kidney cell monolayers.
Ghosh PK; Gupta S; Naik S; Ayyagari A; Naik SR
Indian J Exp Biol; 1998 Sep; 36(9):911-5. PubMed ID: 9854433
[TBL] [Abstract][Full Text] [Related]
17. [In vitro sensitivity of Entamoeba histolytica to metronidazole].
Aguirre-Cruz ML; Valadez-Salazar A; Muñoz O
Arch Invest Med (Mex); 1990; 21 Suppl 1():23-6. PubMed ID: 2136490
[TBL] [Abstract][Full Text] [Related]
18. Entamoeba histolytica: mechanism of decrease of virulence of axenic cultures maintained for prolonged periods.
Olivos A; Ramos E; Nequiz M; Barba C; Tello E; Castañón G; González A; Martínez RD; Montfort I; Pérez-Tamayo R
Exp Parasitol; 2005 Jul; 110(3):309-12. PubMed ID: 15955329
[TBL] [Abstract][Full Text] [Related]
19. Effect of intestinal bacteria on the virulence of Entamoeba histolytica.
Anaya-Velázquez F; Padilla-Vaca F
Arch Med Res; 1992; 23(2):183-5. PubMed ID: 1340289
[TBL] [Abstract][Full Text] [Related]
20. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.
Ferrante A; Rowan-Kelly B
Clin Exp Immunol; 1983 Nov; 54(2):477-85. PubMed ID: 6418422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
